Job ID 515762 Posted since 28-Jul-2026 Organization Siemens Real Estate Field of work Real Estate Company Siemens Ltd., China Experience level Mid-level Professional Job type Full-time Work mode Office/Site only Employment type Fixed Term Location(s) Nanjing
In This Role, Your Responsibilities Will Be: Serve as a critical business partner & drive a consistent strategic vision for EHS across the organization 1. Align with MSol Global EHS & AP EHS strategies, initiatives, systems
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
ABOUT US: As a world leading provider of integrated solutions for the alternative investment industry, Alter Domus (meaning “The Other House” in Latin) is proud to be home to 90% of the top 30 asset managers in
ABOUT US: As a world leading provider of integrated solutions for the alternative investment industry, Alter Domus (meaning “The Other House” in Latin) is proud to be home to 90% of the top 30 asset managers in
ABOUT US: As a world leading provider of integrated solutions for the alternative investment industry, Alter Domus (meaning “The Other House” in Latin) is proud to be home to 90% of the top 30 asset managers in
ABOUT US: As a world leading provider of integrated solutions for the alternative investment industry, Alter Domus (meaning “The Other House” in Latin) is proud to be home to 90% of the top 30 asset managers in
Job Description SummaryThe role ensures that all distributors meet GDP activities comply with regulatory requirements and company standards. The Manager oversees day-to-day quality operations, including deviations, investigations, CAPAs, change controls, and internal and external audits. This position
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job DescriptionJoin Us as a Principal Programmer Analystt – Make an Impact at the Forefront of Innovation We have successfully supported the top 50 pharmaceutical companies and more than 750 biotechs,